Join
Live feed
·
INSIDERFilingvia Quantisnow
Janux Therapeutics Inc. logo

Chief Business Officer Meyer Andrew Hollman sold $25,799 worth of shares (1,879 units at $13.73), decreasing direct ownership by 2% to 83,095 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JANX (Janux Therapeutics Inc.) and more on Quantisnow.